Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Application
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Triptolide-d3 is intended for use as an internal standard for the quantification of triptolide (Item No. 11973) by GC- or LC-MS. Triptolide is a diterpenoid triepoxide that has been found in T. wilfordii and has diverse biological activities.1,2,3,4 It inhibits dCTP pyrophosphatase 1 (Ki = 168 µM), an enzyme that prevents halogenated nucleotides from entering DNA synthesis.1 It reduces viability of A549, H1299, NCI H520, NCI H1650, and H1975 human non-small cell lung cancer (NSCLC) cells when used at a concentration of 50 nM.2 Intranasal administration of liposomes containing triptolide (0.4 mg/kg) reduces tumor growth in a rat orthotopic model of lung cancer. Triptolide (0.2 mg/kg) reduces intestinal inflammation and prevents colon shortening in a mouse model of ulcerative colitis induced by dextran sulfate (Item No. 23250).3 It also inhibits skin allograft rejection and increases graft survival time in mice when administered at a dose of 0.1 mg/kg per day post-transplantation.4
WARNING This product is not for human or veterinary use.
1. Triptolide directly inhibits dCTP pyrophosphatase. Chembiochem 12(11), 1767-1773 (2011).
2. Triptolide suppresses the in vitro and in vivo growth of lung cancer cells by targeting hyaluronan-
3. Therapeutic potential of triptolide as an anti-
4. Immunosuppression of triptolide and its effect on skin allograft survival. Int. J. Immunopharmacol. 14(6), 963-969 (1992).